Annexon (ANNX) Competitors $2.81 +0.34 (+13.77%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$2.82 +0.02 (+0.53%) As of 06:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ANNX vs. PAHC, BGM, ABCL, WVE, VERV, ELVN, NTLA, AKBA, COLL, and ARDXShould you be buying Annexon stock or one of its competitors? The main competitors of Annexon include Phibro Animal Health (PAHC), BGM Group (BGM), AbCellera Biologics (ABCL), WAVE Life Sciences (WVE), Verve Therapeutics (VERV), Enliven Therapeutics (ELVN), Intellia Therapeutics (NTLA), Akebia Therapeutics (AKBA), Collegium Pharmaceutical (COLL), and Ardelyx (ARDX). These companies are all part of the "pharmaceutical products" industry. Annexon vs. Its Competitors Phibro Animal Health BGM Group AbCellera Biologics WAVE Life Sciences Verve Therapeutics Enliven Therapeutics Intellia Therapeutics Akebia Therapeutics Collegium Pharmaceutical Ardelyx Phibro Animal Health (NASDAQ:PAHC) and Annexon (NASDAQ:ANNX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations. Is PAHC or ANNX more profitable? Phibro Animal Health has a net margin of 2.68% compared to Annexon's net margin of 0.00%. Phibro Animal Health's return on equity of 30.51% beat Annexon's return on equity.Company Net Margins Return on Equity Return on Assets Phibro Animal Health2.68% 30.51% 6.89% Annexon N/A -54.45%-46.56% Do analysts rate PAHC or ANNX? Phibro Animal Health currently has a consensus target price of $21.80, suggesting a potential downside of 21.98%. Annexon has a consensus target price of $12.50, suggesting a potential upside of 344.84%. Given Annexon's stronger consensus rating and higher probable upside, analysts plainly believe Annexon is more favorable than Phibro Animal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Phibro Animal Health 2 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67Annexon 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals believe in PAHC or ANNX? 99.3% of Phibro Animal Health shares are held by institutional investors. 50.1% of Phibro Animal Health shares are held by company insiders. Comparatively, 11.9% of Annexon shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has higher valuation and earnings, PAHC or ANNX? Phibro Animal Health has higher revenue and earnings than Annexon. Annexon is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhibro Animal Health$1.02B1.11$2.42M$0.7835.82AnnexonN/AN/A-$138.20M-$1.18-2.38 Does the media prefer PAHC or ANNX? In the previous week, Phibro Animal Health and Phibro Animal Health both had 3 articles in the media. Annexon's average media sentiment score of 1.65 beat Phibro Animal Health's score of 0.51 indicating that Annexon is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phibro Animal Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Annexon 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has more volatility and risk, PAHC or ANNX? Phibro Animal Health has a beta of 0.75, suggesting that its share price is 25% less volatile than the S&P 500. Comparatively, Annexon has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500. SummaryPhibro Animal Health beats Annexon on 9 of the 14 factors compared between the two stocks. Get Annexon News Delivered to You Automatically Sign up to receive the latest news and ratings for ANNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANNX vs. The Competition Export to ExcelMetricAnnexonMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$270.99M$2.88B$5.54B$8.87BDividend YieldN/A2.64%5.39%4.10%P/E Ratio-2.3821.3126.1619.90Price / SalesN/A278.47413.33113.66Price / CashN/A41.4736.1356.90Price / Book1.027.518.055.38Net Income-$138.20M-$55.05M$3.15B$248.50M7 Day Performance14.69%2.07%1.43%2.04%1 Month Performance22.17%4.84%3.62%4.84%1 Year Performance-41.40%5.37%34.92%20.23% Annexon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANNXAnnexon2.2575 of 5 stars$2.81+13.8%$12.50+344.8%-38.4%$270.99MN/A-2.3860News CoveragePositive NewsHigh Trading VolumePAHCPhibro Animal Health3.5806 of 5 stars$25.54-0.5%$21.80-14.6%+67.3%$1.04B$1.02B32.741,940BGMBGM GroupN/A$10.59-11.5%N/AN/A$1.03B$25.10M0.00298ABCLAbCellera Biologics2.2682 of 5 stars$3.43-5.0%$8.33+143.0%+35.4%$1.02B$28.83M-6.12500High Trading VolumeWVEWAVE Life Sciences4.5504 of 5 stars$6.50-2.5%$20.50+215.4%+29.3%$1.01B$104.94M-7.74240Positive NewsVERVVerve Therapeutics3.3149 of 5 stars$11.23-0.6%$14.57+29.8%+124.2%$1.00B$32.33M-5.32110ELVNEnliven Therapeutics2.4893 of 5 stars$20.06-3.0%$39.60+97.4%-4.9%$984.34MN/A-10.4550Analyst ForecastNTLAIntellia Therapeutics4.6711 of 5 stars$9.38-1.9%$33.37+255.7%-51.6%$971.61M$45.57M-1.79600AKBAAkebia Therapeutics4.2759 of 5 stars$3.64-0.3%$6.75+85.4%+278.1%$956.00M$184.91M-17.33430Positive NewsInsider TradeCOLLCollegium Pharmaceutical4.0397 of 5 stars$29.57-1.2%$43.75+48.0%-4.8%$950.08M$631.45M24.24210ARDXArdelyx4.3664 of 5 stars$3.92+6.2%$10.89+177.8%-20.6%$937.90M$333.61M-17.8290 Related Companies and Tools Related Companies PAHC Competitors BGM Competitors ABCL Competitors WVE Competitors VERV Competitors ELVN Competitors NTLA Competitors AKBA Competitors COLL Competitors ARDX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANNX) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Annexon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Annexon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANNX Stock Alerts